{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:09:23Z","timestamp":1791846563393,"version":"4.3.4"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.26335","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T15:06:57Z","timestamp":1660144017000},"page":"e2226335","source":"Crossref","is-referenced-by-count":63,"title":["Durability of Heterologous and Homologous COVID-19 Vaccine Boosts"],"prefix":"10.1001","volume":"5","author":[{"given":"C. Sabrina","family":"Tan","sequence":"first","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-ris Y.","family":"Collier","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyou","family":"Yu","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abishek","family":"Chandrashekar","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"McMahan","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Jacob-Dolan","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"He","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Roy","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake M.","family":"Hauser","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Munt","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Mallory","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mattocks","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Powers","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Meganck","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Rowe","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hemond","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther A.","family":"Bondzie","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate H.","family":"Jaegle","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron G.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Le Gars","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerald","family":"Sadoff","sequence":"additional","affiliation":[{"name":"Janssen Vaccines and Prevention, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[{"name":"Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"5","key":"zoi220751r1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"zoi220751r2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"zoi220751r3","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3.","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi220751r4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of responses after SARS-CoV-2 mRNA-1273 vaccination.","volume":"384","author":"Widge","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi220751r5","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1056\/NEJMc2103916","article-title":"Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19.","volume":"384","author":"Doria-Rose","year":"2021","journal-title":"N Engl J Med"},{"issue":"6561","key":"zoi220751r6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"issue":"21","key":"zoi220751r7","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMc2115596","article-title":"Differential kinetics of immune responses elicited by Covid-19 vaccines.","volume":"385","author":"Collier","year":"2021","journal-title":"N Engl J Med"},{"issue":"7898","key":"zoi220751r8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.","volume":"602","author":"Liu","year":"2021","journal-title":"Nature"},{"issue":"7898","key":"zoi220751r9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.","volume":"602","author":"Carreno","year":"2022","journal-title":"Nature"},{"issue":"5","key":"zoi220751r10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection.","volume":"386","author":"Nemet","year":"2022","journal-title":"N Engl J Med"},{"key":"zoi220751r11","article-title":"Plasma neutralization properties of the SARS-CoV-2 Omicron variant.","author":"Schmidt","year":"2021","journal-title":"medRxiv"},{"issue":"11","key":"zoi220751r12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMc2119912","article-title":"SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination.","volume":"386","author":"Pajon","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi220751r13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.15585\/mmwr.mm7107e2","article-title":"Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance\u2014VISION Network, 10 States, August 2021-January 2022.","volume":"71","author":"Ferdinands","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"zoi220751r14","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a fourth dose of BNT162b2 against Omicron in Israel.","volume":"386","author":"Bar-On","year":"2022","journal-title":"N Engl J Med"},{"issue":"7871","key":"zoi220751r15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"issue":"23","key":"zoi220751r16","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S Vaccine against Covid-19.","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"15","key":"zoi220751r17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1001\/jama.2021.3645","article-title":"Immunogenicity of the Ad26.COV2.S vaccine for COVID-19.","volume":"325","author":"Stephenson","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"zoi220751r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2959","article-title":"Durability of the single-dose Ad26.COV2.S vaccine in the prevention of COVID-19 infections and hospitalizations in the US before and during the Delta variant surge.","volume":"5","author":"Polinski","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi220751r19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination.","volume":"385","author":"Barouch","year":"2021","journal-title":"N Engl J Med"},{"issue":"7847","key":"zoi220751r20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques.","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"issue":"7","key":"zoi220751r21","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals.","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"4","key":"zoi220751r22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19.","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"7898","key":"zoi220751r23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.","volume":"602","author":"Cele","year":"2022","journal-title":"Nature"},{"issue":"7906","key":"zoi220751r24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages.","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"issue":"16","key":"zoi220751r25","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMc2201849","article-title":"Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants.","volume":"386","author":"Yu","year":"2022","journal-title":"N Engl J Med"},{"issue":"7901","key":"zoi220751r26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron.","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"issue":"7901","key":"zoi220751r27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"5","key":"zoi220751r28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"issue":"6529","key":"zoi220751r29","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"6572","key":"zoi220751r30","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"issue":"11","key":"zoi220751r31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00044-21","article-title":"Deletion of the SARS-CoV-2 spike cytoplasmic tail increases infectivity in pseudovirus neutralization assays.","volume":"95","author":"Yu","year":"2021","journal-title":"J Virol"},{"issue":"6558","key":"zoi220751r32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1126\/science.abi4506","article-title":"Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.","volume":"373","author":"Martinez","year":"2021","journal-title":"Science"},{"issue":"11","key":"zoi220751r33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00117-21","article-title":"Coronavirus-specific antibody cross reactivity in rhesus macaques following SARS-CoV-2 vaccination and infection.","volume":"95","author":"Jacob-Dolan","year":"2021","journal-title":"J Virol"},{"issue":"4","key":"zoi220751r34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology.","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"issue":"13","key":"zoi220751r35","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2021.05.040","article-title":"Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.","volume":"184","author":"He","year":"2021","journal-title":"Cell"},{"issue":"11","key":"zoi220751r36","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations.","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi220751r37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa.","volume":"386","author":"Collie","year":"2022","journal-title":"N Engl J Med"},{"key":"zoi220751r38","article-title":"Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: preliminary results of the Sisonke 2 Study.","author":"Gray","year":"2021","journal-title":"medRxiv"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794985\/tan_2022_oi_220751_1659120971.74775.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T15:07:01Z","timestamp":1660144021000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.26335","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]}}}